Concepedia

Melanie Alpaugh

MA

Statistics

Publications

13

Citations

751

H-Index

12

Active since

2012

Affiliations

Université Laval(Current)

Centre hospitalier universitaire de Québec

McMaster University

University of Alberta

Centre National de la Recherche Scientifique

Melanie Alpaugh is an author at Université Laval specializing in life sciences, neurodegenerative diseases, and neurodegenerative disorders.

ORCID

Publications per year

2012–2023

13

Publications

13

Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice

Alba Di Pardo, Vittorio Maglione, Melanie Alpaugh et al. · Proceedings of the National Academy of Sciences · 2012 · 174 citations · Full text

, , +17

The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease

Aurélie de Rus Jacquet, Melanie Alpaugh, Hélèna L. Denis et al. · Nature Communications · 2023 · 113 citations · Full text

, , +17

N6-Furfuryladenine is protective in Huntington’s disease models by signaling huntingtin phosphorylation

Laura E. Bowie, Tamara Maiuri, Melanie Alpaugh et al. · Proceedings of the National Academy of Sciences · 2018 · 103 citations · Full text

, , +17

Disease‐modifying effects of ganglioside GM1 in Huntington's disease models

Melanie Alpaugh, Danny Galleguillos, Juan Forero et al. · EMBO Molecular Medicine · 2017 · 78 citations · Full text

, , +15

Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms

Maria Masnata, Giacomo Sciacca, Alexander Maxan et al. · Acta Neuropathologica · 2019 · 65 citations · Full text

, , +17

1–5 of 13